A Phase II Trial of Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
Latest Information Update: 02 Dec 2021
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel (Primary) ; Toripalimab (Primary)
- Indications Carcinoma; Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 04 Jul 2019 New trial record
- 01 Jul 2019 Status changed from active, no longer recruiting to recruiting.